BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 10073260)

  • 1. Cyclosporine treatment of glomerular diseases.
    Klein M; Radhakrishnan J; Appel G
    Annu Rev Med; 1999; 50():1-15. PubMed ID: 10073260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin treatment of glomerular diseases.
    Radhakrishnan J; Halevy D
    Expert Opin Investig Drugs; 2000 May; 9(5):1053-63. PubMed ID: 11060727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
    Ferrari P; Frey FJ
    Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intravenous immunoglobulins in the treatment of glomerulopathies].
    Floccari F; Palla R; Polito P; Campo S; Aloisi C; Buemi M
    G Ital Nefrol; 2007; 24(4):311-9. PubMed ID: 17659502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and treatment of primary glomerular diseases. Membranous nephropathy, focal segmental glomerulosclerosis and IgA nephropathy.
    Deegens JK; Wetzels JF
    Minerva Urol Nefrol; 2005 Sep; 57(3):211-36. PubMed ID: 15986018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of post-transplant glomerulonephritis].
    Sandrini S; Valerio F
    G Ital Nefrol; 2008; 25 Suppl 44():99-106. PubMed ID: 19048593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
    Yokoyama H; Sugiyama H; Narita I; Saito T; Yamagata K; Nishio S; Fujimoto S; Mori N; Yuzawa Y; Okuda S; Maruyama S; Sato H; Ueda Y; Makino H; Matsuo S
    Clin Exp Nephrol; 2015 Jun; 19(3):496-505. PubMed ID: 25230687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of cyclosporine in glomerular diseases.
    Glassock RJ
    Cleve Clin J Med; 1994; 61(5):363-9. PubMed ID: 7955309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic management of adult idiopathic nephrotic syndrome.
    Alaniz C; Brosius FC; Palmieri J
    Clin Pharm; 1993 Jun; 12(6):429-39. PubMed ID: 8403814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of monoclonal antibodies in the treatment of immune-mediated kidney disease: the state of the art].
    Cravedi P
    G Ital Nefrol; 2012; 29(3):274-82; discussion 292. PubMed ID: 22718450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine in glomerular disease.
    Mowry JA; McCarthy ET
    Semin Nephrol; 1996 Nov; 16(6):548-54. PubMed ID: 9125799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sandimmun in the treatment of chronic glomerulonephritis with the nephrotic syndrome].
    Krasnova TN; Tareeva IE; Shilov EM; Mukhin NA; Miroshnichenko NG
    Ter Arkh; 1997; 69(6):21-3. PubMed ID: 9297266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
    Lee HY; Kim HS; Kang CM; Kim SG; Kim MJ
    Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cyclosporin in treatment of glomerular diseases].
    Krieter DH; Müller GA
    Internist (Berl); 1996 Jan; 37(1):84-8. PubMed ID: 8837833
    [No Abstract]   [Full Text] [Related]  

  • 15. T cell subsets in glomerulonephritis.
    Lin CY; Yang YM; Fu YK
    Int J Pediatr Nephrol; 1986; 7(2):63-8. PubMed ID: 3487514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney transplantation outcomes in patients with IgA nephropathy and other glomerular and non-glomerular primary diseases in the new era of immunosuppression.
    Lionaki S; Makropoulos I; Panagiotellis K; Vlachopanos G; Gavalas I; Marinaki S; Liapis G; Michelakis I; Bokos I; Boletis I
    PLoS One; 2021; 16(8):e0253337. PubMed ID: 34403416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of mycophenolic acid in non-transplant renal diseases.
    Stassen PM; Kallenberg CG; Stegeman CA
    Nephrol Dial Transplant; 2007 Apr; 22(4):1013-9. PubMed ID: 17307748
    [No Abstract]   [Full Text] [Related]  

  • 18. [The immunosuppressive therapy of chronic (Bright's) nephritis].
    Krasnova TN; Shilov EM
    Ter Arkh; 1993; 65(6):88-93. PubMed ID: 8378860
    [No Abstract]   [Full Text] [Related]  

  • 19. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.
    Madan A; Mijovic-Das S; Stankovic A; Teehan G; Milward AS; Khastgir A
    BMC Nephrol; 2016 Mar; 17():37. PubMed ID: 27036111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent type I membranoproliferative glomerulonephritis after renal transplantation and protective role of cyclosporine in acute crescentic transformation.
    Ahsan N; Manning EC; Dabbs DJ; Gifford RR; Yang HC
    Clin Transplant; 1997 Feb; 11(1):9-14. PubMed ID: 9067687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.